骆驼伊氏锥虫病LAMP实验诊断初报

目的为了探索伊氏锥虫病诊断的新方法。方法采用环状介导等温DNA扩增法（LAMP）,分别对随即采样的14峰骆驼进行伊氏锥虫病诊断,并与血液涂片法对比。结果LAMP与血液涂片法检测得出的阳性率分别为35．71％和14．29％。结论LAMP可用来检测骆驼伊氏锥虫病,并且LAMP在等温条件下进行,不需要复杂的仪器,为临床检测锥虫病提供了一个快速简便的分子生物学方法。     

Reproductive performance of camels (Camelus dromedarius) under pastoral management and its influence on herd development

Camels (Camelus dromedarius) produce milk and offspring and provide transport in pastoral husbandry systems in the Afro-Asian dryland belt. The aim of the present study was to investigate the reproductive performance of camels kept under pastoral management in northern Kenya. Using the Progeny History surveying technique, data were collected from 471, 287 and 416 adult Rendille, Gabra and Somali female camels including data on 1506, 789 and 1206 parturitions, respectively. Surveys took place from January to December 1995, but data refer to the 15-year production period preceding the survey. Age at first calving (AFC) was 58.4±1.0 months (LSMeans±S.E.), 63.0±1.1 months and 68.4±1.3 months for the Somali, Rendille and Gabra camels, respectively.The mean calving interval was similar for all three populations with 27.3±0.6 months (LSMeans±S.E.) for Rendille camels, 28.0±0.6 months for Gabra (n=500) and 28.4±0.6 months for Somali camels. The annual calving rate varied between 33% and 46% in the Somali, 19% and 44% in the Gabra and 8% and 86% in the Rendille camel population. Calf mortality rate averaged 25%, 22% and 27% in Rendille, Gabra and Somali camel calves, respectively, and showed highest variation between the years in the Rendille system (5% to 60%).The number of adult breeding females increased by about 20% over a simulation period of 10 years using the status quo reproductive parameters and by about 70% with improved AFC and CI (excluding AFC>78 months and CI>36 months). The results reveal the usual and unusual variation in the reproductive parameters over different years and in the different systems. It is concluded that eliminating unusual variation is a promising way to enhance herd development and reduce risk in the production systems.     

Seroprevalence and risk factors for C. burentii infection in camels in Egypt

Q fever caused by Coxiella burentii, gram negative obligate intracellular bacterium. The disease has been reported in wide range of animals especially ruminants. The available data about the prevalence of Q fever in camels in Egypt are limited. Therefore, the present study aimed to investigate the seroprevalence of C. burnetii among camels and identify the risk factors associated with infection. A total 315 serum samples were collected from three governorates in Egypt during 2018 and examined by an indirect Enzyme linked Immunosorbent Assay (ELISA). The obtained results were subsequent analyzed by chi-square and logistic regression. Generally, the seroprevalence of C. burnetii among camels was 22 %. The results revealed that the seroprevalence of C. burnetii increased in aged female camels in comparison with young one and was higher also in female with history of abortion (OR = 4.6, 95%CI: 2.46–8.76). The infection was significantly increased during autumn season (OR = 9.3, 95%CI: 4.23–20.5). Besides, camels in contact with small ruminants showed high level of infection (OR = 1.12, 95%CI: 0.65–1.93) or camel with heavy tick infestation (OR = 1.08, 95%CI: 0.60–1.92). Our report confirms that the seroprevalence of C. burnetii among camels in Egypt and appropriate control measures should be taken to reduce the transmission of infection to other animal species or human.     

Application of the California mastitis test in intramammary Streptococcus agalactiae and Staphylococcus aureus infections of camels (Camelus dromedarius) in Kenya

A study was conducted on 207 lactating camels in six herds in Kenya to evaluate the California mastitis test (CMT) for the detection of intramammary infections (IMIs) caused by Streptococcus agalactiae and Staphylococcus aureus and to investigate the prevalence of both the pathogens in the camel udder. IMI with S. agalactiae was found in 12% of all camels sampled. IMI with S. aureus was present in 11% of all camels sampled. The herd-level prevalence of IMI varied between 0 and 50% for S. agalactiae and between 0 and 13% for S. aureus. Longitudinal observations over 10–12 months confirmed persistent infections for both pathogens. Observations in one herd suggested that camel pox was a contributing factor in spreading and exacerbating S. agalactiae udder infections.The CMT had quarter-level sensitivities of 77 and 68% for S. agalactiae and S. aureus in camels, respectively. The CMT specificities were 91% for both the pathogens.     

Serosurvey of Coxiella burnetii (Q fever) in Dromedary Camels (Camelus dromedarius) in Laikipia County,Kenya

Dromedary camels (Camelus dromedarius) are an important protein source for people in semi‐arid and arid regions of Africa. In Kenya, camel populations have grown dramatically in the past few decades resulting in the potential for increased disease transmission between humans and camels. An estimated four million Kenyans drink unpasteurized camel milk, which poses a disease risk. We evaluated the seroprevalence of a significant zoonotic pathogen, Coxiella burnetii (Q fever), among 334 camels from nine herds in Laikipia County, Kenya. Serum testing revealed 18.6% positive seroprevalence of Coxiella burnetii (n = 344). Increasing camel age was positively associated with C. burnetii seroprevalence (OR = 5.36). Our study confirmed that camels living in Laikipia County, Kenya, have been exposed to the zoonotic pathogen, C. burnetii. Further research to evaluate the role of camels in disease transmission to other livestock, wildlife and humans in Kenya should be conducted.     

Experimental infection of camels with bluetongue virus

Three camels aged 4–5 years were experimentally infected with Bluetongue virus serotype 1 (BTV-1) and were observed for 75 days. No clinical signs of disease were observed throughout the experiment, however all three animals seroconverted and developed BTV-1 specific neutralising antibodies after challenge. All three camels developed a viraemia from 7 days post infection albeit at a lower level than that usually observed in experimental infections of sheep and cattle. Virus was isolated from the blood of all three animals suggesting that camels may act as a reservoir for BTV and play an important role in its transmission.     

Application of the California mastitis test in intramammary Streptococcus agalactiae and Staphylococcus aureus infections of camels (Camelus dromedarius) in Kenya

A study was conducted on 207 lactating camels in six herds in Kenya to evaluate the California mastitis test (CMT) for the detection of intramammary infections (IMIs) caused by Streptococcus agalactiae and Staphylococcus aureus and to investigate the prevalence of both the pathogens in the camel udder. IMI with S. agalactiae was found in 12% of all camels sampled. IMI with S. aureus was present in 11% of all camels sampled. The herd-level prevalence of IMI varied between 0 and 50% for S. agalactiae and between 0 and 13% for S. aureus. Longitudinal observations over 10–12 months confirmed persistent infections for both pathogens. Observations in one herd suggested that camel pox was a contributing factor in spreading and exacerbating S. agalactiae udder infections.

The CMT had quarter-level sensitivities of 77 and 68% for S. agalactiae and S. aureus in camels, respectively. The CMT specificities were 91% for both the pathogens.     

The disposition of diclofenac in camels after intravenous administration

The pharmacokinetics of diclofenac was studied in camels (Camelus dromedarus) (n=6) following intravenous (i.v.) administration of a dose of 2.5 mg kg(-1) body weight. The metabolism and urinary detection time were also studied. The results obtained (median and range) were as follows: the terminal elimination half-life (t(1/2beta)) was 2.35 (1.90-2.73)h, total body clearance (Cl(T)) was 0.17 (0.16-0.21)lh kg(-1). The volume of distribution at steady state (V(SS)) was 0.31 (0.21-0.39)l(-1)kg(-1), the volume of the central compartment of the two compartment pharmacokinetic model (V(C)) was 0.15 (0.11-0.17)l kg(-1). Five metabolites of diclofenac were tentatively identified in urine and were excreted mainly in conjugate form. The main metabolite was identified as hydroxy diclofenac. Both diclofenac and hydroxy diclofenac, appear to be the main elimination route for diclofenac when administered i.v. in camels. Diclofenac could be identified up to 4 days following i.v. administration in camels using a sensitive gas chromatography/mass spectrometry (GC/MS) method.